ArticleScientific reports2021

COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response.

Serhiy Souchelnytskyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.